Xaviar M. Jones MD , Russell G. Rogers PhD , Kara Tsi BS , Thassio Mesquita PhD , Alberto Marchevsky MD , Alessandra Ciullo PhD , Salwa Soussi PhD , Nunzio Bottini MD, PhD , Francesco Boin MD , Ahmed G.E. Ibrahim PhD, MPH , Eduardo Marbán MD, PhD
{"title":"Macrophages Contribute to Cardiac Fibrosis and Diastolic Dysfunction in Systemic Sclerosis","authors":"Xaviar M. Jones MD , Russell G. Rogers PhD , Kara Tsi BS , Thassio Mesquita PhD , Alberto Marchevsky MD , Alessandra Ciullo PhD , Salwa Soussi PhD , Nunzio Bottini MD, PhD , Francesco Boin MD , Ahmed G.E. Ibrahim PhD, MPH , Eduardo Marbán MD, PhD","doi":"10.1016/j.jacbts.2024.08.008","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":14831,"journal":{"name":"JACC: Basic to Translational Science","volume":"9 12","pages":"Pages 1432-1434"},"PeriodicalIF":8.4000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11733755/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC: Basic to Translational Science","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2452302X24003218","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
期刊介绍:
JACC: Basic to Translational Science is an open access journal that is part of the renowned Journal of the American College of Cardiology (JACC). It focuses on advancing the field of Translational Cardiovascular Medicine and aims to accelerate the translation of new scientific discoveries into therapies that improve outcomes for patients with or at risk for Cardiovascular Disease. The journal covers thematic areas such as pre-clinical research, clinical trials, personalized medicine, novel drugs, devices, and biologics, proteomics, genomics, and metabolomics, as well as early phase clinical trial methodology.